The latest Alimentary Pharmacology & Therapeutics performs a validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis.
Outlier identification in colorectal surgery should separate elective and nonelective service components, reports the latest issue of the Diseases of the Colon & Rectum.
This month's Digestive Diseases & Sciences examines the efficacy and safety of endoscopic submucosal dissection for superficial squamous esophageal neoplasia.
A study in September's issue of the Alimentary Pharmacology & Therapeutics reviews adherence to Rome criteria in therapeutic trials in functional dyspepsia.
The most recent issue of the Digestive Diseases & Sciences determined whether methylated gene markers in stool normalize after colorectal cancer resection.
The most recent issue of the Alimentary Pharmacology & Therapeutics examines the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis.
The most recent issue of the Alimentary Pharmacology & Therapeutics evaluates clinical predictors of recurrent Clostridium difficile infection in out-patients.
The latest issue of the American Journal of Gastroenterology compares the demographics, medication exposure, treatment patterns, and outcomes of patients with C. difficile in 2 different time periods.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .